Fixing the PBM Problem Is the Silver Bullet for Lowering Drug Costs in America
Common Sense PBM Reforms Are Needed Now to Make Medicines More Affordable FOR IMMEDIATE RELEASE August 10, 2022 Washington, DC – Mark...
News
- 2 days ago
How the failure to cap insulin prices impacts Latinos
Failure to include a monthly $35 insulin cap in the climate and health care bill that passed the Senate last weekend could especially...
- Aug 4
Is your health plan covering the lowest-cost drugs?
It’s commonly known that the cost of prescription drugs in the U.S. has been rising well above inflation, 7.5% in some cases. Ironically...
- Aug 2
The Democrats' Deal Only Targets One Piece of Our Drug-Pricing Problem
Last week, Senate Majority Leader Chuck Schumer and Pesky 49th Vote Joe Manchin announced they’d reached a deal on a budget...
- Jul 25
Opinion: Congress should seize opportunity to cut medication costs for consumers
Prices are on the rise on just about every category of goods and services: food, housing, and healthcare. Consumers could use a break....
- Jul 22
Opinion: These 'Rebates' Don't Result in Savings
Two former Trump administration officials have taken to the Wall Street Journal to defend the practices of pharmacy benefit managers, the...
- Jul 21
Opinion: Drug Prices Are Falling, If You Know Where to Look
Prescription-drug prices are actually falling if you strip out the massive and growing rebates that pharmaceutical companies must pay to...
- Jul 20
Powerful Senate Democrat outlines ‘plenty’ more drug pricing reforms to follow Medicare negotiation
Democrats may be closer than ever to passing sweeping drug pricing reforms, but Sen. Ron Wyden says there’s more to do. During a STAT...
- Jul 15
Statement on Near-Term Congressional Efforts to Improve Prescription Drug Affordability
Congress should prioritize affordability of medicines needed by Medicare beneficiaries suffering from diabetes and other chronic...
- Jul 3
Opinion: San Diegans with Mental Health Issues Forego Treatment Due to High Cost
Rising health care costs continue to put treatment out of reach for vulnerable communities in San Diego and across California, including...
- Jul 2
FTC Goes After PBMs, Warns Of Legal Action
Last month, the Federal Trade Commission (FTC) voted unanimously (5-0) to examine rising list prices of insulin, but also to probe...
- Jun 30
PBMs are inflating the cost of generic drugs. They must be reined in
hese are not comfortable days in Washington for pharmacy benefit managers, the highly consolidated group of intermediaries that sit...
- Jun 28
Former CVS exec accuses it of ripping off seniors, taxpayers
The top leadership of CVS Health directed an illegal scheme to work across the corporation’s sprawling subsidiaries to drive up drug...
- Jun 27
Talking Solutions: The Story Behind Prescription Drug Prices In Nevada
According to a 2021 Gallup poll, an estimated 18 million Americans can’t afford to pay for their much-needed prescription drugs. Across...
- Jun 22
PBM reform bill that boosts FTC powers inches closer to passage in Senate
Legislation aimed at curbing several pharmacy benefit manager practices such as spread pricing cleared a key obstacle to passage in the...
- Jun 22
Senators unroll bipartisan plan to curb insulin prices
Top senators unveiled a bipartisan bill Wednesday that aims to curb the high cost of insulin, a lifesaving drug that some Americans have...
- Jun 21
Washington ups pressure on PBMs with more aggressive FTC policy, congressional ask for GAO study
Pressure is increasing on pharmacy benefit managers as the middlemen come under rising scrutiny from Washington for their role in rising...
- Jun 17
FTC targets insulin, threatening to go after PBM-pharma deals that steer into 'commercial bribery'
The Federal Trade Commission voted unanimously yesterday (5-0) to adopt a new policy specifically targeting rising insulin prices, but...
- Jun 16
Let My Doctors Decide: A VICTORY FOR PATIENTS
The recent decision by the Federal Trade Commission to study the business practices of pharmacy benefit managers (PBMs) is a significant...
- Jun 16
FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes
In a notable move, the Federal Trade Commission put drugmakers and pharmacy benefit managers on notice that the agency will “ramp up...